Deals Watch

For some time now, Medius has noted that corporate acquisitions are in decl...

October 2017 has proved to be a very interesting month, with our Deal Watch...

The trend we have noted previously in the decline in the number of pharma M...

There is plenty of evidence that the number and value of biopharma M&A and ...

The cheque books have been out in force in July, and payments were for subs...

Good morning, good morning

London, 9th June 2017 - Biotech and Money is delighted to announce an excit...

Following the scarcity of billion dollar headline deals in March, this mont...

deal watch